[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349437-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349437-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","adgrf4-and-adgrl4-as-novel-prognostic-biomarkers-and-potential-therapeutic-implications-in-stomach-adenocarcinoma","ADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma","","Background: This study evaluates differential expression of adhesion G protein-coupled receptor (ADGR) genes in stomach adenocarcinoma (STAD), their association with patient prognosis, and potential therapeutic implications. Methods: Gene expression datasets from TCGA and GTEx were analyzed with DESeq2, followed by external validation using GEO cohorts. Prognostic impact was assessed with multivariate Cox and Kaplan–Meier analyses, while immune microenvironment features used ESTIMATE and CIBERSORT. Immunohistochemistry on 50 STAD tissue pairs validated protein expression, and drug sensitivity was inferred with oncoPredict. Results and conclusion: ADGRF4/ADGRL4 were upregulated and independently linked to poor outcomes, correlated with tumor microenvironment and immune infiltration, and ADGRL4 associated with sensitivity to AZD7762.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/adgrf4-and-adgrl4-as-novel-prognostic-biomarkers-and-potential-therapeutic-implications-in-stomach-adenocarcinoma/349437/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/adgrf4-and-adgrl4-as-novel-prognostic-biomarkers-and-potential-therapeutic-implications-in-stomach-adenocarcinoma/349437.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study?","Question",{"text":63,"@type":64},"To determine whether ADGRF4 and ADGRL4 show differential expression in stomach adenocarcinoma, relate to prognosis, and reflect potential therapeutic relevance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were gene expression and differential expression analyses performed?",{"text":68,"@type":64},"Expression profiles from STAD and normal gastric tissues were obtained from TCGA and GTEx and analyzed using DESeq2.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supported the prognostic role of ADGRF4 and ADGRL4?",{"text":72,"@type":64},"Multivariate Cox risk models and Kaplan–Meier survival analyses showed independent association of ADGRF4/ADGRL4 with poor prognosis, further confirmed by external GEO validation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349437,1790210770,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Wang et al. BMCGastroenterology (2026) 26:416 BMC Gastroenterology  \n[https://doi.org/10.1186/s12876-026-04913-3](https://doi.org/10.1186/s12876-026-04913-3)  \nRESEARCH Open Access  \nADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma  \nJia-Hui Wang1, Ming-Jun Li2, Dan-Dan Zang3, Xiao-Wei Wang2 and Peng Huang2*  \nAbstract  \nBackground This study explored the differential expression of adhesion G protein-coupled receptor (ADGR) genes in stomach adenocarcinoma (STAD), evaluated their association with STAD prognosis, and explored their potential therapeutic implications.  \nMethods The gene expression profiles of STAD and normal gastric tissues were obtained from TCGA and GTEx databases and analyzed using the DEseq2 R package. External validation was performed using three GEO datasets. Co-expression patterns of ADGRF4 and ADGRL4 with immune-related molecules were analyzed using Spearman correlation. The prognostic values of ADGRs were evaluated using multivariate Cox risk models and Kaplan–Meier survival analyses. The tumor microenvironment composition and immune infiltration were analyzed using the ESTIMATE R package and CIBERSORT algorithm. GO and KEGG enrichment analyses were performed using DAVID. Immunohistochemistry was conducted to validate gene expression in 50 pairs of STAD and adjacent normal tissues. Drug sensitivity was analyzed using the oncoPredict R package.  \nResults ADGRF4 and ADGRL4 were significantly upregulated in STAD tissues and independently associated with poor prognosis and the tumor microenvironment composition. Functional enrichment analysis revealed that ADGRF4 was primarily associated with epithelial development and neuroactive ligand–receptor interaction, whereas ADGRL4 was linked to extracellular matrix organization and calcium signaling pathways. Immunohistochemistry confirmed the significantly higher expression of both proteins in gastric cancer tissues than in normal tissues. External validation using GEO datasets confirmed the upregulation and prognostic significance of ADGRL4 . Drug sensitivity analysis indicated that ADGRL4 expression was significantly correlated with sensitivity to the Chk1/Chk2 inhibitor AZD7762 . Conclusion ADGRF4 and ADGRL4 were significantly overexpressed in STAD and independently associated with poor prognosis. Expression of these genes was correlated with changes in tumor microenvironment and immune cell infiltration, indicating their potential association in STAD progression. These findings suggest that ADGRF4 and ADGRL4 could serve as novel prognostic biomarkers with potential therapeutic significance in gastric cancer. Keywords Stomach adenocarcinoma, Adhesion G protein-coupled receptors, ADGRF4, ADGRL4, Tumor microenvironment  \n*Correspondence:  \nPeng Huang  \n[huangpeng1822@qq.com](huangpeng1822@qq.com)  \n1Department of General Surgery, Anshan Central Hospital, Anshan, China  \n2Department of General Surgery, Panjin Central Hospital, No. 32 Liaohe Middle Road, Xinglongtai District, Panjin, China  \n3Department of Pathology, Panjin Central Hospital, Panjin, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or ex","cbCaidH9L8PI2eqx","https://ap.wps.com/l/cbCaidH9L8PI2eqx","pdf",9028846,17,"English","# Background\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To determine whether ADGRF4 and ADGRL4 show differential expression in stomach adenocarcinoma, relate to prognosis, and reflect potential therapeutic relevance.\"},{\"question\":\"How were gene expression and differential expression analyses performed?\",\"answer\":\"Expression profiles from STAD and normal gastric tissues were obtained from TCGA and GTEx and analyzed using DESeq2.\"},{\"question\":\"What evidence supported the prognostic role of ADGRF4 and ADGRL4?\",\"answer\":\"Multivariate Cox risk models and Kaplan–Meier survival analyses showed independent association of ADGRF4/ADGRL4 with poor prognosis, further confirmed by external GEO validation.\"}]","ADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma | PDF",1790083310,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0df9deafed589d3b0e641d94a0cadfe.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89f80bc3478a27baf95afaffa472fa7e.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6ea84331c7954a5d2ebb16d9080ff83.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae025a5bb4babea6d8acaff226dca0af.webp",980,1306]